Jinghua Pharmaceutical Group Co., Ltd.
002349.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.68B
Close$
$16.59
114.6% upside
Current Fair Value
114.6% upsideUndervalued by 114.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.68 Billion |
|---|---|
| Enterprise Value | $6.91 Billion |
| Dividend Yield | $0.09 (0.97%) |
| Earnings per Share | $0.27 |
| Beta | 0.12 |
| Outstanding Shares | 814,180,908 |
Return
| Return on Equity | 7.95% |
|---|---|
| Return on Assets | 6.20% |
| Return on Invested Capital | 9.70% |
Valuation & Multiples
| P/E Ratio | 33.65 |
|---|---|
| PEG | 1259.4 |
| Price to Sales | 7.73 |
| Price to Book Ratio | 2.58 |
| Enterprise Value to Revenue | 4.66 |
| Enterprise Value to EBIT | 21.83 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jinghua Pharmaceutical Group Co., Ltd.
1,462 employees
CEO: Jian Cheng Established in 1957 and headquartered in Nantong, China, Jinghua Pharmaceutical Group Co., Ltd. is a Chinese enterprise dedicated to the complete process of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, encom...